Does hormone therapy impact cognition in patients with prostate cancer? A systematic review and meta‐analysis

Hormone therapy, which is widely prescribed for prostate cancer, might induce cognitive impairment and affect the autonomy of elderly patients. However, previous studies provided conflicting results. The aim of this systematic review and meta‐analysis was to synthesize the longitudinal impact of hormone therapy on objective (cognitive tests) and subjective (questionnaires) cognition.

• Publication year

  2024

• Venue

  Cancer

• Publication date

  2024-02-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cncr.35210PMID 38306301
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in high-risk localized prostate cancer: Staging and management.

  2023cited by this paper
• A scoping review of cognitive assessment tools and domains for chemotherapy-induced cognitive impairments in cancer survivors

  2023cited by this paper
• Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors

  2022cited by this paper
• Practice effects in cognitive assessments three years later in non-carriers but not in symptom-free mutation carriers of autosomal-dominant Alzheimer's disease: Exemplifying procedural learning and memory?

  2022cited by this paper
• Risk of cognitive impairment in men with advanced prostate cancer treated with NHAs: A systematic review and network meta‐analysis

  2022cited by this paper
• Effect of androgen deprivation therapy on cognitive functioning in men with prostate cancer: A systematic review

  2021cited by this paper
• Risk of Cognitive Effects in Comorbid Patients With Prostate Cancer Treated With Androgen Receptor Inhibitors.

  2021cited by this paper
• Low Serum Testosterone Concentrations Are Associated With Poor Cognitive Performance in Older Men but Not Women

  2021cited by this paper
• A 2‐year prospective analysis of insomnia as a mediator of the relationship between androgen deprivation therapy and perceived cognitive function in men with prostate cancer

  2021cited by this paper
• Fatigue prevalence in men treated for prostate cancer: A systematic review and meta-analysis

  2021cited by this paper
• Androgen deprivation therapy and radiation for prostate cancer—cognitive impairment, sleep, symptom burden: a prospective study

  2021cited by this paper
• Association of Chemotherapy, Enzalutamide, Abiraterone, and Radium 223 With Cognitive Function in Older Men With Metastatic Castration-Resistant Prostate Cancer

  2021cited by this paper
• Androgen deprivation therapy and cognitive decline—associations with brain connectomes, endocrine status, and risk genotypes

  2021cited by this paper
• Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: Preliminary findings

  2020cited by this paper
• Effects of androgen deprivation therapy on cognitive functions in patients with metastatic prostate cancer: A multicentric, prospective study of the Society of Urological Surgery Andrology group

  2020cited by this paper
• Investigating and dealing with publication bias and other reporting biases in meta‐analyses of health research: A review

  2020cited by this paper
• Prostate Cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2020influential reference
• Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS Study.

  2020cited by this paper
• Characterization of Models for Identifying Physical and Cognitive Frailty in Older Adults With Diabetes: Systematic Review and Meta-Analysis

  2020cited by this paper
• Formulating questions to explore complex interventions within qualitative evidence synthesis

  2019cited by this paper
• Epidemiology of Prostate Cancer

  2019cited by this paper
• A review of prostate cancer treatment impact on the CNS and cognitive function

  2019cited by this paper
• Effect Size Guidelines, Sample Size Calculations, and Statistical Power in Gerontology

  2019cited by this paper
• Impact of anxio-depressive symptoms and cognitive function on oral anticancer therapies adherence

  2019cited by this paper
• Results of a Real-world Study of Enzalutamide and Abiraterone Acetate With Prednisone Tolerability (REAAcT).

  2019influential reference
• Changes in cerebral metabolic activity in men undergoing androgen deprivation therapy for non-metastatic prostate cancer

  2018cited by this paper
• Impact of Androgen Deprivation Therapy on Self‐Reported Cognitive Function in Men with Prostate Cancer

  2018cited by this paper
• Cognitive Impairment in Men with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta‐Analysis

  2018cited by this paper
• Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the observational AQUARiUS study

  2018influential reference
• Effects of long‐term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer

  2017cited by this paper
• Cognitive impairment among prostate cancer patients: An overview of reviews

  2017cited by this paper
• Estrogens in Male Physiology.

  2017cited by this paper
• Cognitive Impacts of Estrogen Treatment in Androgen-Deprived Males: What Needs to be Resolved

  2017cited by this paper
• Cognitive Function in Patients With Prostate Cancer Receiving Luteinizing Hormone-Releasing Hormone Analogues: A Prospective, Observational, Multicenter Study.

  2017cited by this paper
• Rayyan—a web and mobile app for systematic reviews

  2016cited by this paper
• Subjective or Objective Measures of Cognitive Functioning-What's More Important?

  2016cited by this paper
• Cognition and Cognitive Impairment in Older Adults with Cancer

  2016cited by this paper
• Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison.

  2015influential reference
• The Impact of Age on Cognition

  2015cited by this paper
• Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists.

  2014influential reference
• Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis

  2014influential reference
• Effect of leuprolide on serum amyloid-β peptide levels and memory in patients with prostate cancer with biochemical recurrence.

  2013cited by this paper
• Effects of Androgen Deprivation on Cerebral Morphometry in Prostate Cancer Patients – An Exploratory Study

  2013cited by this paper
• Effects of androgen deprivation on brain function in prostate cancer patients – a prospective observational cohort analysis

  2012cited by this paper
• Neuropsychological assessment, 5th ed.

  2012cited by this paper
• International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.

  2011cited by this paper
• Changes in neuronal activation patterns in response to androgen deprivation therapy: a pilot study

  2010cited by this paper
• Subjective cognitive dysfunction in breast cancer patients: a systematic review

  2010cited by this paper
• Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer.

  2010influential reference
• A randomized controlled trial of add-back estrogen or placebo on cognition in men with prostate cancer receiving an antiandrogen and a gonadotropin-releasing hormone analog.

  2010cited by this paper
• Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer.

  2010cited by this paper
• Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non‐metastatic prostate cancer

  2009cited by this paper
• Introduction to Meta‐Analysis

  2009cited by this paper
• Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study

  2005cited by this paper
• Estradiol and cognition during androgen deprivation in men with prostate carcinoma

  2005cited by this paper
• Associations between Serum Testosterone Fall and Cognitive Function in Prostate Cancer Patients

  2004cited by this paper
• Quality of life compared during pharmacological treatments and clinical monitoring for non‐localized prostate cancer: a randomized controlled trial

  2004cited by this paper
• One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men.

  2004cited by this paper
• Quality of life compared during pharmacological treatments and clinical monitoring for non‐localized prostate cancer: a randomized controlled trial

  2004cited by this paper
• Androgen deprivation and cognition in prostate cancer

  2003cited by this paper
• The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.

  2003cited by this paper
• Coping and health‐related quality of life in men with prostate cancer randomly assigned to hormonal medication or close monitoring

  2002cited by this paper
• Statistics to tell the truth, the whole truth, and nothing but the truth: formulae, illustrative numerical examples, and heuristic interpretation of effect size analyses for neuropsychological researchers.

  2001cited by this paper
• Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis

  2000cited by this paper

• Changes in perceived cognitive functioning following a codesigned online group cognitive rehabilitation for prostate cancer survivors on androgen deprivation therapy: Series of single-case experimental designs.

  2026cites this paper
• Occupational Therapy Intervention to Mitigate Chemotherapy-Induced Cognitive Impairment Among Breast Cancer Patients: A Systematic Review.

  2026cites this paper
• [Optimizing management of metastatic castration-sensitive prostate cancer: From therapeutic advances to personalized care].

  2026cites this paper
• Neuropsychological functioning in non-CNS cancer patients

  2025cites this paper
• Raised a eunuch: a case report of testicular loss without androgen replacement in a pre-pubescent boy

  2025cites this paper
• Impact of androgen receptor pathway inhibitors on cognitive function in older adults treated for metastatic prostate cancer

  2025cites this paper
• Research progress on cognitive frailty in elderly patients with prostate cancer

  2025cites this paper
• Cancer-related cognitive impairment: a review of National Institutes of Health‑Funded grants (2017-2024).

  2025cites this paper
• Neuropsychological and central neurologic effects of cancer immunotherapy: the start of a new challenge

  2025cites this paper
• Patient-centered outcomes and preference between darolutamide and enzalutamide: insights from the ODENZA trial

  2025influential citation
• Effect of hormonal therapies for prostate cancer on cognition: The ongoing search for clarity

  2024cites this paper
• Recent advances in polysaccharide-based drug delivery systems for cancer therapy: a comprehensive review

  2024cites this paper